Lömskt och omfattande utbrott av clostridium difficile - Ändrade städrutiner och täta utvärderingar halverade infektionerna

Lakartidningen

Volumn 111, Issue 1-2, 2014, Pages 24-

  Toepfer, Michael ^a   Magnusson, Cecilia ^b   Norén, Torbjörn ^c   Hansen, Inger ^d   Iveroth, Peter ^a   Offenbartl, Karsten ^d  

^a Landstinget i Jönköpings län ^*  (Sweden)

^b Infektionskliniken   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d Höglandssjukhuset Eksjö   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891888765     PISSN: 00237205     EISSN: 16527518     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15(12):1067-79.
2. Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63-73.
3. Wiegand PN, Nathwani D, Wilcox MH, et al. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect. 2012;81(1):1-14.
4. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40(1):1-15.
5. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693-703.
6. Bloomfield MG, Sherwin JC, Gkrania-Klotsas E. Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review. J Hosp Infect. 2012;82(1):1-12.
7. Owens RC Jr, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46 (Suppl 1):S19-31.
8. Shaughnessy MK, Micielli RL, De-Pestel DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201-6.
9. Lanzas C, Dubberke ER, Lu Z, et al. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol. 2011;32(6):553-61.
10. Vonberg RP, Kuijper EJ, Wilcox MH, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect. 2008;14 (Suppl 5):2-20.
11. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile- associated disease in North America and Europe. Clin Microbiol Infect. 2006;12 (Suppl 6):2-18.
12. Barbut F, Jones G, Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis. 2011;24(4):370-6.
13. Merrigan M, Venugopal A, Mallozzi M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192(19):4904-11.
14. Walk ST, Micic D, Jain R, et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis. 2012;55(12):1661-8.
15. Carlson PE Jr, Walk ST, Bourgis AE, et al. The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Anaerobe. Epub 20 april 2013.
16. Norén T, Åkerlund T, Back E, et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol. 2004;42(8):3635-43.
17. Karlström O, Fryklund B, Tullus K, et al. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C difficile Study Group. Clin Infect Dis. 1998;26(1):141-5.
18. Karlström O, Fryklund B, Tullus K, et al. Samhällsförvärvad C difficile-associerad diarré en realitet. Färre recept och mera tvål. Läkartidningen. 1997;94(23):2187-92.
19. Svenungsson B. Clostridium difficile-associerad diarré - ett ökande problem. Ge mindre antibiotika och förbättra hygienen! Läkartidningen. 1996;93(35):2931-4.
20. Svenungsson B, Norén T. Clostridium difficile-associerad diarré hotar patientsäkerheten! Läkartidningen. 2008(28):2001-2.
21. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55.
22. Viseur N, Lambert M, Delmee M, et al. Nosocomial and non-nosocomial Clostridium difficile infections in hospitalised patients in Belgium: compulsory surveillance data from 2008 to 2010. Euro Surveill. 2011;16(43).
23. Duerden BI. Contribution of a government target to controlling Clostridium difficile in the NHS in England. Anaerobe. 2011;17(4):175-9.
24. Daneman N, Stukel TA, Ma X, et al. Reduction in Clostridium difficile infection rates after mandatory hospital public reporting: findings from a longitudinal cohort study in Canada. PLoS medicine. 2012;9(7):e1001268.
25. Åkerlund T, Alefjord I, Dohnhammar U, et al. Geographical clustering of cases of infection with moxifloxacin- resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009. Euro Surveill. 2011;16(10).
26. Aldeyab MA, Kearney MP, Scott MG, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother. 2012;67(12):2988-96.
27. Landstinget i Jönköpings län. Vårdhygieniska riktlinjer - Clostridium difficile infektion (CDI), misstänkt eller konstaterad. 2 okt 2013 [citerad 15 okt 2013]. http://www.lj.se/infopage.jsf?childId=16503&nodeId=31555
28. Hughes GJ, Nickerson E, Enoch DA, et al. Impact of cleaning and other interventions on the reduction of hospital-acquired Clostridium difficile infections in two hospitals in England assessed using a breakpoint model. J Hosp Infect. 2013;84(3):227-34.
29. Landstinget i Jönköpings län. Clostridium difficile-infektion (CDI). Statistik över nya fall. 30 maj 2013 [citerad 15 okt 2013]. http://www.lj.se/infopage.jsf?nodeId=41413